Scholars Central

Short communicationPublished 22 Jul 2022

Type 2 Diabetes Mellitus as A Risk Factor for Development of Hepatocellular Carcinoma: Case-Control Hospital Based Study

Authors: Ibrahim El Bayoumy

Journal of Medical Oncology

Volume 5 · Issue 4 · Pages 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

AIM: To study the relationships between Type 2 diabetes mellitus (DM2) and the risk of hepatocellular carcinoma (HCC). METHODS: We studied the association between DM2 and HCC in a large case-control study that enrolled 255 Egyptian patients with HCC (71.4% males, mean age 62± 10.2 years) matched for age and sex and free from hepatocellular carcinoma 305 patients constituted the control group. RESULTS: Prevalence of DM2 was significantly higher in HCC patients (29.1.2% vs 10.2.7%; OR = 3.35 95%CI: 1.31-3.29.).The highest prevalence of diabetes was found in patients with hepatitis C was 30% followed by hepatitis B infection 20%. CONCLUSION: DM2 in our patients is associated with a 3-fold increase risk of HCC so that we encourage prompt screening for HCC in diabetic patients with cirrhosis. Key words: type 2 diabetes ,hepatocellular carcinoma ,insulin resistance

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Medical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ibrahim El Bayoumy”